Literature DB >> 24859019

Glucocorticoids induce apoptosis by inhibiting microRNA cluster miR‑17‑92 expression in chondrocytic cells.

Wenhua Xing1, Lixia Hao2, Xuejun Yang1, Feng Li1, Hongjun Huo1.   

Abstract

Sustained treatment with glucocorticoids (GCs) has frequently been observed to impair skeletal development. However, the influence of GCs on chondrocytes, which have a key role in skeletal development, has been rarely reported. HCS‑2/8 cells were selected as an in vitro model of human chondrocytes to assess the apoptosis induced by GCs and determine the role of the microRNA‑17‑92 (miR‑17‑92) cluster in the regulation of apoptosis. It was demonstrated that dexamethasone (Dex) was able to induce apoptosis and high levels of expression of apoptosis‑associated molecules in HCS‑2/8 chondrocytic cells, and that expression of the miR‑17‑92 cluster was inhibited during Dex‑induced apoptosis. In conclusion, the present study suggested that inhibition of the expression of the miR‑17‑92 cluster contributed to the Dex‑induced apoptosis in chondrocytes. The results suggest that microRNAs have an important role in glucocorticoid‑induced impairment to chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859019     DOI: 10.3892/mmr.2014.2253

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

1.  Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.

Authors:  Peng Liu; Mario Baumgart; Marco Groth; Jürgen Wittmann; Hans-Martin Jäck; Matthias Platzer; Jan P Tuckermann; Ulrike Baschant
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

Review 2.  The role of microRNAs in glucocorticoid action.

Authors:  Sally A Clayton; Simon W Jones; Mariola Kurowska-Stolarska; Andrew R Clark
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

3.  MicroRNA expression signature and target prediction in familial and sporadic primary macronodular adrenal hyperplasia (PMAH).

Authors:  Xiao-Gang Tan; Jie Zhu; Liang Cui
Journal:  BMC Endocr Disord       Date:  2022-01-05       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.